Bio-Rad Laboratories (BIO)

NYSE Health Care Life Sciences Tools & Services S&P MidCap 400

$381.57

+12.57 (+3.41%)

Close of Nov 06, 2026 · end-of-day data

Source: Bio-Rad Laboratories's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.07B	$2.16B	$2.29B	$2.31B	$2.55B	$2.92B	$2.80B	$2.67B	$2.57B	$2.58B
Cost of revenue	$929.74M	$972.45M	$1.07B	$1.05B	$1.11B	$1.28B	$1.23B	$1.24B	$1.19B	$1.24B
Gross profit	$1.14B	$1.19B	$1.22B	$1.26B	$1.44B	$1.64B	$1.57B	$1.43B	$1.38B	$1.34B
Research & development	$205.71M	$250.16M	$199.20M	$202.71M	$217.76M	$260.64M	$256.90M	$247.40M	$295.90M	$275.60M
Selling, general & admin	$814.70M	$806.79M	$834.78M	$824.62M	$798.80M	$877.12M	$827.80M	$841.70M	$814.00M	$844.30M
Operating income	$55.72M	$119.25M	-$103.34M	$229.66M	$421.33M	$500.34M	$482.60M	$337.80M	$269.00M	$47.20M
Interest expense	$23.38M	$23.01M	$23.96M	$23.42M	$21.86M	$1.55M	$38.10M	$49.40M	$48.90M	$49.00M
Pre-tax income	$41.56M	$97.81M	$512.66M	$2.26B	$4.92B	$5.45B	-$4.70B	-$850.10M	-$2.34B	$995.50M
Income tax	$15.56M	-$24.44M	$147.04M	$502.41M	$1.10B	$1.19B	-$1.08B	-$212.80M	-$498.30M	$235.60M
Net income	$26.00M	$122.25M	$365.61M	$1.76B	$3.81B	$4.25B	-$3.63B	-$637.30M	-$1.84B	$759.90M
EBITDA	$198.62M	$267.95M	$34.76M	$363.86M	$559.93M	$637.94M	$619.90M	$483.70M	$420.60M	$212.60M
EPS (basic)	$0.88	$4.12	$12.25	$58.93	$128.13	$142.61	$-121.79	$-21.82	$-65.36	$27.87
EPS (diluted)	$0.88	$4.07	$12.10	$58.27	$126.47	$140.83	$-121.79	$-21.82	$-65.36	$27.85
Diluted shares	29.65M	30.03M	30.23M	30.18M	30.16M	30.21M	29.79M	29.21M	28.21M	27.28M
Gross margin	55.0%	55.0%	53.4%	54.4%	56.5%	56.1%	55.9%	53.4%	53.7%	51.9%
Operating margin	2.7%	5.5%	-4.5%	9.9%	16.6%	17.1%	17.2%	12.6%	10.5%	1.8%
Net margin	1.3%	5.7%	16.0%	76.1%	149.8%	145.6%	-129.5%	-23.9%	-71.9%	29.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$456.26M	$383.82M	$431.53M	$660.67M	$662.21M	$470.78M	$434.20M	$403.80M	$488.10M	$529.80M
Short-term investments	$383.18M	$371.15M	$413.27M	$453.97M	$328.91M	$399.13M	$1.36B	$1.20B	$1.18B	$1.01B
Receivables	$372.35M	$464.85M	$392.44M	$392.67M	$419.42M	$423.54M	$494.64M	$489.00M	$452.50M	$460.60M
Inventory	$524.96M	$594.80M	$583.82M	$554.01M	$622.25M	$572.24M	$719.32M	$780.50M	$760.00M	$740.70M
Total current assets	$1.84B	$1.98B	$2.02B	$2.18B	$2.14B	$1.99B	$3.16B	$3.05B	$3.03B	$2.91B
Goodwill	$477.10M	$506.10M	$219.80M	$264.10M	$291.90M	$347.30M	$406.50M	$413.60M	$410.50M	$579.80M
Total assets	$3.85B	$4.27B	$5.61B	$8.01B	$12.97B	$17.80B	$13.50B	$12.30B	$9.36B	$10.58B
Total current liabilities	$471.32M	$502.70M	$450.80M	$905.50M	$631.54M	$680.94M	$568.71M	$522.80M	$467.80M	$517.00M
Long-term debt	$434.19M	$434.58M	$438.94M	$13.58M	$12.26M	$10.51M	$1.20B	$1.20B	$1.20B	$1.20B
Total debt	$434.19M	$434.58M	$438.94M	$13.58M	$12.26M	$10.51M	$1.20B	$1.20B	$1.20B	$1.20B
Total liabilities	$1.27B	$1.34B	$1.59B	$2.25B	$3.09B	$4.11B	$3.89B	$3.56B	$2.79B	$3.12B
Shareholders' equity	$2.58B	$2.93B	$4.02B	$5.76B	$9.89B	$13.69B	$9.62B	$8.74B	$6.57B	$7.45B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$216.07M	$104.14M	$285.49M	$457.90M	$584.97M	$669.46M	$194.40M	$374.90M	$455.20M	$532.20M
Capital expenditures	$141.44M	$111.33M	$129.82M	$98.53M	$108.56M	$133.75M	$112.80M	$156.70M	$165.60M	$157.60M
Free cash flow	$74.63M	-$7.20M	$155.67M	$359.37M	$476.41M	$535.72M	$81.60M	$218.20M	$289.60M	$374.60M
Investing cash flow	-$213.88M	-$175.57M	-$186.98M	-$208.89M	-$69.89M	-$797.38M	-$1.21B	$20.20M	-$160.20M	-$189.70M
Financing cash flow	$9.02M	$341.00K	-$48.68M	-$22.76M	-$523.04M	-$55.43M	$973.60M	-$425.60M	-$218.80M	-$283.20M
Share buybacks	$0	$2.92M	$48.91M	$28.00M	$100.00M	$50.00M	$215.70M	$428.70M	$203.60M	$295.50M
Stock-based compensation	$19.70M	$23.40M	$27.80M	$35.60M	$41.60M	$51.20M	$60.90M	$61.30M	$62.30M	$58.00M
Depreciation & amortization	$142.90M	$148.70M	$138.10M	$134.20M	$138.60M	$137.60M	$137.30M	$145.90M	$151.60M	$165.40M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$681.12M	$610.80M	$638.50M	$649.70M	$667.50M	$585.40M	$651.60M	$653.00M	$693.20M	$592.10M	$651.00M	$656.40M
Cost of revenue	$314.81M	$284.90M	$283.40M	$293.80M	$325.60M	$279.40M	$306.30M	$309.60M	$348.00M	$282.70M	$305.20M	$327.80M
Gross profit	$366.30M	$325.90M	$355.10M	$355.90M	$342.00M	$306.00M	$345.30M	$343.40M	$345.20M	$309.40M	$345.80M	$328.60M
Research & development	$63.87M	$66.40M	$58.90M	$91.00M	$79.60M	$73.50M	$60.50M	$71.30M	$70.30M	$62.90M	$61.20M	$71.40M
Selling, general & admin	$207.12M	$214.90M	$194.70M	$200.40M	$204.00M	$208.80M	$207.70M	$206.80M	$221.00M	$212.40M	$212.00M	$257.10M
Operating income	$95.32M	$44.60M	$101.50M	$64.50M	$58.30M	$23.70M	$77.10M	$65.30M	-$118.90M	$34.10M	$72.60M	-$49.70M
Interest expense	$12.32M	$12.30M	$12.30M	$12.10M	$12.20M	$12.00M	$12.60M	$12.30M	$12.10M	$12.30M	$12.10M	$12.30M
Pre-tax income	$428.40M	$491.10M	-$2.79B	$861.60M	-$908.90M	$83.40M	$414.00M	-$431.10M	$929.20M	-$689.80M	$542.10M	$538.70M
Income tax	$78.66M	$107.20M	-$620.80M	$208.40M	-$193.10M	$19.40M	$96.20M	-$89.20M	$209.20M	-$162.70M	$170.70M	$80.10M
Net income	$349.70M	$383.90M	-$2.17B	$653.20M	-$715.80M	$64.00M	$317.80M	-$341.90M	$720.00M	-$527.10M	$371.40M	$458.60M
EPS (basic)	$12.15	$13.46	$-76.26	$23.37	$-25.57	$2.29	$11.67	$-12.70	$26.41	$-19.55	$13.89	$17.13
EPS (diluted)	$12.14	$13.45	$-76.26	$23.34	$-25.57	$2.29	$11.67	$-12.70	$26.39	$-19.55	$13.85	$17.02
Diluted shares	—	28.54M	28.39M	27.98M	—	27.95M	27.23M	26.92M	—	26.96M	26.81M	26.95M
Gross margin	53.8%	53.4%	55.6%	54.8%	51.2%	52.3%	53.0%	52.6%	49.8%	52.3%	53.1%	50.1%
Operating margin	14.0%	7.3%	15.9%	9.9%	8.7%	4.0%	11.8%	10.0%	-17.2%	5.8%	11.2%	-7.6%
Net margin	51.3%	62.9%	-339.2%	100.5%	-107.2%	10.9%	48.8%	-52.4%	103.9%	-89.0%	57.1%	69.9%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$403.80M	$433.30M	$406.90M	$410.40M	$488.10M	$521.40M	$369.30M	$395.80M	$529.80M	$507.20M	$517.00M	$465.30M
Short-term investments	$1.20B	$1.21B	$1.21B	$1.21B	$1.18B	$1.14B	$1.00B	$1.02B	$1.01B	$1.06B	$1.10B	$1.20B
Receivables	$489.00M	$444.81M	$445.51M	$461.94M	$452.50M	$424.70M	$469.90M	$464.70M	$460.60M	$426.20M	$441.80M	$422.60M
Inventory	$780.50M	$783.37M	$803.69M	$804.28M	$760.00M	$790.10M	$798.80M	$783.20M	$740.70M	$770.50M	$780.60M	$783.90M
Total current assets	$3.05B	$3.06B	$3.06B	$3.06B	$3.03B	$3.04B	$2.81B	$2.84B	$2.91B	$2.94B	$3.02B	$3.08B
Goodwill	$413.60M	$412.82M	$412.12M	$415.10M	$410.50M	$414.60M	$581.60M	$578.70M	$579.80M	$577.10M	$574.30M	$573.00M
Total assets	$12.30B	$12.61B	$9.69B	$10.60B	$9.36B	$9.53B	$10.21B	$9.70B	$10.58B	$9.79B	$10.25B	$10.78B
Total current liabilities	$522.80M	$466.15M	$486.96M	$497.94M	$467.80M	$506.60M	$548.90M	$522.30M	$517.00M	$917.00M	$961.30M	$969.10M
Long-term debt	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$802.90M	$803.00M	$803.10M
Total debt	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$1.20B	$802.90M	$803.00M	$803.10M
Total liabilities	$3.56B	$3.56B	$2.91B	$3.12B	$2.79B	$2.85B	$3.09B	$2.96B	$3.12B	$2.94B	$3.08B	$3.18B
Shareholders' equity	$8.74B	$9.05B	$6.78B	$7.49B	$6.57B	$6.68B	$7.13B	$6.74B	$7.45B	$6.85B	$7.17B	$7.60B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$81.00M	$69.80M	$97.60M	$163.60M	$124.20M	$129.90M	$116.50M	$120.90M	$164.90M	$108.10M	$98.70M	$96.40M
Capital expenditures	$42.27M	$40.20M	$42.30M	$40.20M	$42.90M	$34.40M	$45.70M	$31.70M	$45.80M	$30.00M	$32.00M	$31.20M
Free cash flow	$38.74M	$29.60M	$55.30M	$123.40M	$81.30M	$95.50M	$70.80M	$89.20M	$119.10M	$78.10M	$66.70M	$65.20M
Investing cash flow	$72.19M	-$43.10M	-$30.90M	-$55.70M	-$30.50M	$2.90M	-$115.40M	-$43.00M	-$34.20M	-$93.20M	-$66.70M	-$145.90M
Financing cash flow	-$200.57M	$0	-$96.60M	-$96.00M	-$26.20M	-$97.70M	-$136.30M	-$52.50M	$3.30M	-$44.00M	-$27.60M	-$1.60M
Share buybacks	$199.97M	$4.70M	$101.00M	$97.90M	$0	$101.90M	$140.20M	$53.40M	$0	$47.80M	$31.50M	$0
Stock-based compensation	$16.20M	$15.30M	$15.00M	$15.60M	$16.40M	$15.30M	$11.90M	$14.90M	$15.90M	$15.00M	$14.50M	$15.50M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.